{"ticker": {"uuid": "eddcb728-753b-4183-af71-0344d33016bd", "symbol": "TELA", "name": "Tela Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "TELA - TELA Bio Inc Dividends", "summary": "This page provides a detailed financial overview of TELA Bio Inc (TELA), including its stock performance, market capitalization, income, sales, and various financial ratios. It also lists key statistics like insider ownership, institutional ownership, analyst recommendations, and", "url": "https://finviz.com/stock?t=TELA&ta=1&p=m&ty=dv&r=max", "source_name": "Finviz", "published_at": "2026-07-03T01:10:22", "published_display": "03 Jul 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio Inc. (TELA) Shows Modest Uptick as Stock Tests Key Resistance - Volume Weighted Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQSDNwSXZrQklPaEJRU3o0V0N3QVhvMVMyeDFhRV9PTk93M3BoR2JxOHNhNE4xalRKVnAwU3NMV3B4T1o0bEYyejgxWV9tdS1DZEVteUlrUmRNQzJfRVZISXJDaEViOWVlZkpENUtleE9Ta3JKMjVqeWhwN0lsbkp0QTRNdHN0ZjhtaExzcGxYSWZmM2Y2dEdQclViN1lGbFcyWWZvYUtXZVVHSjktZFlPVzFRYzd5bW8?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA - TELA Bio Inc Options", "summary": "This article provides a detailed financial overview of TELA Bio Inc (TELA) as of June 29, 2026. It includes key financial metrics such as market capitalization, income, sales, EPS, various ratios, and stock performance data. The company's short interest, insider/institutional own", "url": "https://finviz.com/stock?t=TELA&ty=oc&ov=chain_date&e=2026-08-21", "source_name": "Finviz", "published_at": "2026-06-27T18:11:58", "published_display": "27 Jun 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio, Inc. Actuals & Estimates (NASDAQ:TELA)", "summary": "This article provides an overview of TELA Bio, Inc. (NASDAQ: TELA) stock performance, financial actuals, and analyst estimates. It details the company's current stock price, market capitalization, volatility, and future outlook based on analyst forecasts, alongside historical hig", "url": "https://www.tradingview.com/symbols/NASDAQ-TELA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T06:39:31", "published_display": "26 Jun 2026 06:39", "sentiment": "negative", "sentiment_pct": 40, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of TELA Bio, Inc. \u2013 NASDAQ:TELA", "summary": "This article provides a brief overview of TELA Bio, Inc. (NASDAQ:TELA) specifically focusing on its forward price-to-sales ratio. It's presented within the context of TradingView's financial data offerings, indicating the company's financial metrics are available for analysis on ", "url": "https://www.tradingview.com/symbols/NASDAQ-TELA/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T04:40:45", "published_display": "26 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of TELA Bio, Inc. \u2013 NASDAQ:TELA", "summary": "This article focuses on the \"Price to book forward\" metric for TELA Bio, Inc. (NASDAQ: TELA). It appears to be a financial data presentation rather than an analytical piece, originating from a platform like TradingView which provides market data and financial tools.", "url": "https://www.tradingview.com/symbols/NASDAQ-TELA/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T17:39:32", "published_display": "25 Jun 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of TELA Bio, Inc. \u2013 NASDAQ:TELA", "summary": "This article focuses on the forward price-to-earnings ratio of TELA Bio, Inc. (NASDAQ: TELA). It appears to be a financial data page from TradingView, displaying basic financial metrics for the company. The page also provides navigational options for further financial analysis, n", "url": "https://www.tradingview.com/symbols/NASDAQ-TELA/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-24T21:41:44", "published_display": "24 Jun 2026 21:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio Inc (TELA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for TELA Bio Inc (TELA), detailing its business segments. As of the latest update (April 6), the company's revenue streams are primarily OviTex, OviTex PRS, and \"Other,\" with OviTex contributing the largest proportion. The data presented ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tela/revenue", "source_name": "TradingKey", "published_at": "2026-06-19T13:40:13", "published_display": "19 Jun 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio Inc (TELA) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of TELA Bio Inc (TELA), focusing on its support and resistance levels, various technical indicators, and moving averages. It highlights the stock's current price momentum score and suggests a \"Sell\" signal based on certain indicators. Th", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tela/technical", "source_name": "TradingKey", "published_at": "2026-06-17T22:09:57", "published_display": "17 Jun 2026 22:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "TELA Bio (NASDAQ: TELA) director Thomas Paul files initial Form 3 ownership", "summary": "TELA Bio, Inc. director Thomas Paul has filed an initial Form 3, which is a mandatory statement of beneficial ownership for company insiders. This filing identifies him as a director but does not report any specific stock transactions, derivative positions, or shareholdings withi", "url": "https://www.stocktitan.net/sec-filings/TELA/form-3-tela-bio-inc-initial-statement-of-beneficial-ownership-8e2bb0093ee6.html", "source_name": "Stock Titan", "published_at": "2026-06-11T22:40:03", "published_display": "11 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio (NASDAQ: TELA) director Guido Neels granted stock and long-term options", "summary": "TELA Bio director Guido Neels was granted stock awards totaling 23,600 and 11,925 shares, respectively, at a $0.00 strike price, along with two stock option grants for 17,335 and 17,550 shares at an exercise price of $0.935, expiring on June 9, 2036. These awards are routine comp", "url": "https://www.stocktitan.net/sec-filings/TELA/form-4-tela-bio-inc-insider-trading-activity-48df2f998bc4.html", "source_name": "Stock Titan", "published_at": "2026-06-11T22:13:01", "published_display": "11 Jun 2026 22:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio (NASDAQ: TELA) grants director new stock and options", "summary": "TELA Bio director Joseph H. Capper has received new equity awards, including restricted stock units (RSUs) and stock options, as compensation. The grants consist of 11,675 and 11,925 RSUs, and options for 17,335 and 17,550 shares with an exercise price of $0.935 per share, expiri", "url": "https://www.stocktitan.net/sec-filings/TELA/form-4-tela-bio-inc-insider-trading-activity-f7fdf071be29.html", "source_name": "Stock Titan", "published_at": "2026-06-11T22:11:01", "published_display": "11 Jun 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio Inc Annual Shareholders Meeting Transcript", "summary": "TELA Bio Inc held its 2026 Annual Shareholders Meeting in an all-virtual format, presided over by Director and Chairman of the Board, Doug Evans. The meeting aimed to maximize stockholder participation through increased accessibility. The transcript records the official calling t", "url": "https://www.gurufocus.com/stock/TELA/transcripts/8908485", "source_name": "GuruFocus", "published_at": "2026-06-09T13:40:41", "published_display": "09 Jun 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "TELA Bio (NASDAQ: TELA) holder reports 2.44M shares, 5.5% stake", "summary": "Laurence W. Lytton has filed an amended Schedule 13G/A, reporting a beneficial ownership of 2,442,341 shares of TELA Bio, Inc. (NASDAQ: TELA) Common Stock, which constitutes a 5.5% stake in the company. This percentage is based on 44,740,371 shares outstanding as of March 16, 202", "url": "https://www.stocktitan.net/sec-filings/TELA/schedule-13g-a-tela-bio-inc-amended-passive-investment-disclosure-0a8206d03c41.html", "source_name": "Stock Titan", "published_at": "2026-05-15T17:08:55", "published_display": "15 May 2026 17:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report", "summary": "TELA Bio, Inc. (NASDAQ:TELA) shares dropped 10% after its first-quarter results, despite revenues meeting expectations. Analysts subsequently lowered their average price target by 35% to US$2.25, indicating increased pessimism about the company's intrinsic value, even though loss", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-tela/tela-bio/news/analysts-have-been-trimming-their-tela-bio-inc-nasdaqtela-pr", "source_name": "Simply Wall Street", "published_at": "2026-05-15T12:08:55", "published_display": "15 May 2026 12:08", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQTklRNTRPQy1icktoRFkwNEQ2aXhRZnpmZU1FZmJyYmRqUW1xeEFpZl9aUUZfbEtlb3JyT3BZcjFqZVEyOW5sbUFjcTg0WmpwMWhUeGNqVmlKejcyLTNERjJBdUNibm44emNDWks3c1FXM05pT2ZHY2NHTV9vUDFkOXFjMWFqVTVIUlM1MXF5UUkwaVNFSTk2RVE5a0dWSXJYNlE?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio (NASDAQ: TELA) Q1 2026 revenue edges up as net loss widens", "summary": "TELA Bio reported a slight increase in Q1 2026 revenue to $19.1 million, a 3% rise year-over-year, primarily driven by higher OviTex unit sales and international demand. Despite this, the company's net loss widened to $12.3 million due to increased interest expenses from a new cr", "url": "https://www.stocktitan.net/sec-filings/TELA/10-q-tela-bio-inc-quarterly-earnings-report-e17a263a0cb1.html", "source_name": "Stock Titan", "published_at": "2026-05-13T19:40:02", "published_display": "13 May 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ...", "summary": "", "url": "https://finance.yahoo.com/news/tela-bio-inc-tela-q1-050154292.html", "source_name": "GuruFocus.com", "published_at": "2026-05-13T05:01:54+00:00", "published_display": "13 May 2026 05:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What To Expect From TELA Bio Inc (TELA) Q1 2026 Earnings", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/expect-tela-bio-inc-tela-132336039.html", "source_name": "GuruFocus.com", "published_at": "2026-05-11T13:23:36+00:00", "published_display": "11 May 2026 13:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOcUVLM0tfOHVwWkFOQ09udTVLb2J0VjlUQkF0VFdmS0pLMzg0MUhyQldZNXFLbEk4YXktMmNqLXpQaC0wbHhlWVcyOFN3blJGYzZXbXhnZVliZXB5NDlpNFVTdGkxNU5DRjBCWExzWmNDZWpKNTJka0pQSjNKRFJxV1RTZXFsQ1Nsek5zT3NpcnNSSkpsYkMwdnFuX3FkOWxpbFl6R2F3UWNrUUhIaFVHUXZ4cUQtdTNvOF84QnJKdWdLVE9oTV9TbWJRQXBZcmJDdS1uSnhaUHZ0dEU?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "by_tier": {"direct": [{"title": "TELA - TELA Bio Inc Dividends", "summary": "This page provides a detailed financial overview of TELA Bio Inc (TELA), including its stock performance, market capitalization, income, sales, and various financial ratios. It also lists key statistics like insider ownership, institutional ownership, analyst recommendations, and", "url": "https://finviz.com/stock?t=TELA&ta=1&p=m&ty=dv&r=max", "source_name": "Finviz", "published_at": "2026-07-03T01:10:22", "published_display": "03 Jul 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio Inc. (TELA) Shows Modest Uptick as Stock Tests Key Resistance - Volume Weighted Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxQSDNwSXZrQklPaEJRU3o0V0N3QVhvMVMyeDFhRV9PTk93M3BoR2JxOHNhNE4xalRKVnAwU3NMV3B4T1o0bEYyejgxWV9tdS1DZEVteUlrUmRNQzJfRVZISXJDaEViOWVlZkpENUtleE9Ta3JKMjVqeWhwN0lsbkp0QTRNdHN0ZjhtaExzcGxYSWZmM2Y2dEdQclViN1lGbFcyWWZvYUtXZVVHSjktZFlPVzFRYzd5bW8?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA - TELA Bio Inc Options", "summary": "This article provides a detailed financial overview of TELA Bio Inc (TELA) as of June 29, 2026. It includes key financial metrics such as market capitalization, income, sales, EPS, various ratios, and stock performance data. The company's short interest, insider/institutional own", "url": "https://finviz.com/stock?t=TELA&ty=oc&ov=chain_date&e=2026-08-21", "source_name": "Finviz", "published_at": "2026-06-27T18:11:58", "published_display": "27 Jun 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio, Inc. Actuals & Estimates (NASDAQ:TELA)", "summary": "This article provides an overview of TELA Bio, Inc. (NASDAQ: TELA) stock performance, financial actuals, and analyst estimates. It details the company's current stock price, market capitalization, volatility, and future outlook based on analyst forecasts, alongside historical hig", "url": "https://www.tradingview.com/symbols/NASDAQ-TELA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T06:39:31", "published_display": "26 Jun 2026 06:39", "sentiment": "negative", "sentiment_pct": 40, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of TELA Bio, Inc. \u2013 NASDAQ:TELA", "summary": "This article provides a brief overview of TELA Bio, Inc. (NASDAQ:TELA) specifically focusing on its forward price-to-sales ratio. It's presented within the context of TradingView's financial data offerings, indicating the company's financial metrics are available for analysis on ", "url": "https://www.tradingview.com/symbols/NASDAQ-TELA/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T04:40:45", "published_display": "26 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of TELA Bio, Inc. \u2013 NASDAQ:TELA", "summary": "This article focuses on the \"Price to book forward\" metric for TELA Bio, Inc. (NASDAQ: TELA). It appears to be a financial data presentation rather than an analytical piece, originating from a platform like TradingView which provides market data and financial tools.", "url": "https://www.tradingview.com/symbols/NASDAQ-TELA/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T17:39:32", "published_display": "25 Jun 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of TELA Bio, Inc. \u2013 NASDAQ:TELA", "summary": "This article focuses on the forward price-to-earnings ratio of TELA Bio, Inc. (NASDAQ: TELA). It appears to be a financial data page from TradingView, displaying basic financial metrics for the company. The page also provides navigational options for further financial analysis, n", "url": "https://www.tradingview.com/symbols/NASDAQ-TELA/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-24T21:41:44", "published_display": "24 Jun 2026 21:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio Inc (TELA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for TELA Bio Inc (TELA), detailing its business segments. As of the latest update (April 6), the company's revenue streams are primarily OviTex, OviTex PRS, and \"Other,\" with OviTex contributing the largest proportion. The data presented ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tela/revenue", "source_name": "TradingKey", "published_at": "2026-06-19T13:40:13", "published_display": "19 Jun 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio Inc (TELA) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of TELA Bio Inc (TELA), focusing on its support and resistance levels, various technical indicators, and moving averages. It highlights the stock's current price momentum score and suggests a \"Sell\" signal based on certain indicators. Th", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tela/technical", "source_name": "TradingKey", "published_at": "2026-06-17T22:09:57", "published_display": "17 Jun 2026 22:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio (NASDAQ: TELA) director Thomas Paul files initial Form 3 ownership", "summary": "TELA Bio, Inc. director Thomas Paul has filed an initial Form 3, which is a mandatory statement of beneficial ownership for company insiders. This filing identifies him as a director but does not report any specific stock transactions, derivative positions, or shareholdings withi", "url": "https://www.stocktitan.net/sec-filings/TELA/form-3-tela-bio-inc-initial-statement-of-beneficial-ownership-8e2bb0093ee6.html", "source_name": "Stock Titan", "published_at": "2026-06-11T22:40:03", "published_display": "11 Jun 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio (NASDAQ: TELA) director Guido Neels granted stock and long-term options", "summary": "TELA Bio director Guido Neels was granted stock awards totaling 23,600 and 11,925 shares, respectively, at a $0.00 strike price, along with two stock option grants for 17,335 and 17,550 shares at an exercise price of $0.935, expiring on June 9, 2036. These awards are routine comp", "url": "https://www.stocktitan.net/sec-filings/TELA/form-4-tela-bio-inc-insider-trading-activity-48df2f998bc4.html", "source_name": "Stock Titan", "published_at": "2026-06-11T22:13:01", "published_display": "11 Jun 2026 22:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio (NASDAQ: TELA) grants director new stock and options", "summary": "TELA Bio director Joseph H. Capper has received new equity awards, including restricted stock units (RSUs) and stock options, as compensation. The grants consist of 11,675 and 11,925 RSUs, and options for 17,335 and 17,550 shares with an exercise price of $0.935 per share, expiri", "url": "https://www.stocktitan.net/sec-filings/TELA/form-4-tela-bio-inc-insider-trading-activity-f7fdf071be29.html", "source_name": "Stock Titan", "published_at": "2026-06-11T22:11:01", "published_display": "11 Jun 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio Inc Annual Shareholders Meeting Transcript", "summary": "TELA Bio Inc held its 2026 Annual Shareholders Meeting in an all-virtual format, presided over by Director and Chairman of the Board, Doug Evans. The meeting aimed to maximize stockholder participation through increased accessibility. The transcript records the official calling t", "url": "https://www.gurufocus.com/stock/TELA/transcripts/8908485", "source_name": "GuruFocus", "published_at": "2026-06-09T13:40:41", "published_display": "09 Jun 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio (NASDAQ: TELA) holder reports 2.44M shares, 5.5% stake", "summary": "Laurence W. Lytton has filed an amended Schedule 13G/A, reporting a beneficial ownership of 2,442,341 shares of TELA Bio, Inc. (NASDAQ: TELA) Common Stock, which constitutes a 5.5% stake in the company. This percentage is based on 44,740,371 shares outstanding as of March 16, 202", "url": "https://www.stocktitan.net/sec-filings/TELA/schedule-13g-a-tela-bio-inc-amended-passive-investment-disclosure-0a8206d03c41.html", "source_name": "Stock Titan", "published_at": "2026-05-15T17:08:55", "published_display": "15 May 2026 17:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Have Been Trimming Their TELA Bio, Inc. (NASDAQ:TELA) Price Target After Its Latest Report", "summary": "TELA Bio, Inc. (NASDAQ:TELA) shares dropped 10% after its first-quarter results, despite revenues meeting expectations. Analysts subsequently lowered their average price target by 35% to US$2.25, indicating increased pessimism about the company's intrinsic value, even though loss", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-tela/tela-bio/news/analysts-have-been-trimming-their-tela-bio-inc-nasdaqtela-pr", "source_name": "Simply Wall Street", "published_at": "2026-05-15T12:08:55", "published_display": "15 May 2026 12:08", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQTklRNTRPQy1icktoRFkwNEQ2aXhRZnpmZU1FZmJyYmRqUW1xeEFpZl9aUUZfbEtlb3JyT3BZcjFqZVEyOW5sbUFjcTg0WmpwMWhUeGNqVmlKejcyLTNERjJBdUNibm44emNDWks3c1FXM05pT2ZHY2NHTV9vUDFkOXFjMWFqVTVIUlM1MXF5UUkwaVNFSTk2RVE5a0dWSXJYNlE?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio (NASDAQ: TELA) Q1 2026 revenue edges up as net loss widens", "summary": "TELA Bio reported a slight increase in Q1 2026 revenue to $19.1 million, a 3% rise year-over-year, primarily driven by higher OviTex unit sales and international demand. Despite this, the company's net loss widened to $12.3 million due to increased interest expenses from a new cr", "url": "https://www.stocktitan.net/sec-filings/TELA/10-q-tela-bio-inc-quarterly-earnings-report-e17a263a0cb1.html", "source_name": "Stock Titan", "published_at": "2026-05-13T19:40:02", "published_display": "13 May 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio Inc (TELA) Q1 2026 Earnings Call Highlights: Strong European Growth and Strategic U.S. ...", "summary": "", "url": "https://finance.yahoo.com/news/tela-bio-inc-tela-q1-050154292.html", "source_name": "GuruFocus.com", "published_at": "2026-05-13T05:01:54+00:00", "published_display": "13 May 2026 05:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What To Expect From TELA Bio Inc (TELA) Q1 2026 Earnings", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/expect-tela-bio-inc-tela-132336039.html", "source_name": "GuruFocus.com", "published_at": "2026-05-11T13:23:36+00:00", "published_display": "11 May 2026 13:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxOcUVLM0tfOHVwWkFOQ09udTVLb2J0VjlUQkF0VFdmS0pLMzg0MUhyQldZNXFLbEk4YXktMmNqLXpQaC0wbHhlWVcyOFN3blJGYzZXbXhnZVliZXB5NDlpNFVTdGkxNU5DRjBCWExzWmNDZWpKNTJka0pQSjNKRFJxV1RTZXFsQ1Nsek5zT3NpcnNSSkpsYkMwdnFuX3FkOWxpbFl6R2F3UWNrUUhIaFVHUXZ4cUQtdTNvOF84QnJKdWdLVE9oTV9TbWJRQXBZcmJDdS1uSnhaUHZ0dEU?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 98, "total_relevant": 31, "sentiment_summary": {"positive": 1, "negative": 4, "neutral": 26, "score": 48, "total": 31, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 80, "events": [{"event": "earnings", "label": "Earnings", "weight": 8.94, "count": 19}, {"event": "general", "label": "Market update", "weight": 4.95, "count": 9}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 0.85, "latest_week": "2026-07-10", "one_week_move": 17.4, "four_week_move": -1.5, "twelve_week_move": 24.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.364662, "market_dynamics_buy_signal": false, "relative_strength": -37.021937, "fair_value_gap": -74.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 39.7497, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+17.4% over one week, -1.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 10}, {"label": "Stock Titan", "count": 5}, {"label": "TradingView", "count": 4}, {"label": "Finviz", "count": 2}, {"label": "TradingKey", "count": 2}, {"label": "GuruFocus.com", "count": 2}, {"label": "StockStory", "count": 2}, {"label": "Donan\u0131mHaber", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 20}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 19}, {"label": "Market update", "count": 9}, {"label": "Analyst action", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "20", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+17.4% over one week, -1.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "TELA - TELA Bio Inc Dividends"}], "updated_at": "2026-07-16T11:43:23.215699+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}